Company profile
Canopy Growth Corporation
NASDAQ: CGC · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Smiths Falls, ONCIK 0001737927Reports USD
#289 of 1,418 Healthcare companies by revenue73rd-percentile growth
EA Score
59CFH 55DQ 58GM 69SS 72
v0.1 · 65/100 weight · provisional
↑ workforce scale, 3-yr revenue growth · ↓ Altman-Z, disclosure history
Methodology →Revenue TTM
$225.8M
Rev growth YoY (TTM)
+16.8%
Net income (FY)
-$190.2M
Employees
1,128
as of 2026-08-12
Market cap
$422.2M
as of 2026-08-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$205.9M284.6M CAD2026
Net income-$190.2M-262.9M CAD2026
Operating income-$117.0M-161.7M CAD2026
Total assets$802.6M1.1B CAD2026
Liabilities$302.1M421.1M CAD2026
Equity$500.5M697.6M CAD2026
Revenue trend
FY2026 – FY2026 · USD
FY26
FY26
FY26
FY25
FY26
FY26
FY26
FY26
Revenue by segment
Filed disclosures · FY2025
By product
Other Revenue0%
By geography
CANADA65%
GERMANY22%
USA10%
Other Geographical Area3%
The read
What is Canopy Growth Corporation’s revenue?
Canopy Growth Corporation booked $205.9M in FY2026 revenue, growing 35% year over year — faster than most Healthcare companies we track, at a -92.4% net margin.
Peers · Healthcare
Vanda Pharmaceuticals Inc.63CTreace Medical Concepts, Inc.55CEstablishment Labs Holdings Inc.59CCytek Biosciences, Inc.58CSI-BONE, Inc.70BStrata Critical Medical, Inc.60CKey facts
CEOLuc Mongeau
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersSmiths Falls, ON
ExchangeNASDAQ: CGC
Employees1,128
IPO date2014-04-07
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.